Core Insights - Enovis is positioned as a challenger brand in the orthopedic market, competing against the major players in the industry [1] - The company boasts an innovative portfolio that spans the entire patient continuum, from prevention to recovery, which enhances its market appeal [1] - Enovis has strategically balanced its portfolio with 50% of its revenue coming from the U.S. and 50% from international markets, as well as a split of 50% in products and revenue (P&R) and 50% in reconstruction (Recon) [1] - Within the reconstruction segment, Enovis has a balanced focus on extremities and large implants, each accounting for 50% of that segment [1]